RC
TNDM icon

Roundview Capital’s Tandem Diabetes Care TNDM Stock Holding History

Roundview Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,594
Closed -$201K – 339
2024
Q4 		$201K Buy
5,594
+250
+5% +$8.46K 0.01% 323
2024
Q3 		$227K Hold
5,344
– – 0.02% 321
2024
Q2 		$215K Buy
+5,344
New +$223K 0.02% 309
2023
Q2 		– Sell
-5,344
Closed -$217K – 327
2023
Q1 		$217K Hold
5,344
– – 0.02% 305
2022
Q4 		$240K Buy
+5,344
New +$242K 0.03% 274
2022
Q2 		– Sell
-2,746
Closed -$319K – 291
2022
Q1 		$319K Sell
2,746
-6,116
-69% -$714K 0.03% 254
2021
Q4 		$1.33M Hold
8,862
– – 0.13% 165
2021
Q3 		$1.06M Hold
8,862
– – 0.12% 176
2021
Q2 		$863K Buy
+8,862
New +$790K 0.1% 199

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Roundview Capital's TNDM Position: Q1 2025 in Review

Roundview Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 5,594 shares — an estimated $201K sold.

Roundview Capital first reported a position in TNDM in Q2 2021 and held it in 9 quarters. The position peaked at $1.33M in Q4 2021. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Roundview Capital reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Roundview Capital sold 5,594 Tandem Diabetes Care shares in Q1 2025, an estimated $201K.
  • Roundview Capital first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 9 quarters.
  • Roundview Capital's Tandem Diabetes Care position peaked at $1.33M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Roundview Capital's 13F filing for Q1 2025, filed 6 May 2025.